Cyclerion Therapeutics (CYCN) Accumulated Expenses (2018 - 2025)

Cyclerion Therapeutics' Accumulated Expenses history runs 8 years deep, the most recent figure standing at $13000.0 for Q4 2025.

• In Q4 2025, Accumulated Expenses fell 95.41% year-over-year to $13000.0; the TTM figure through Dec 2025 stood at $13000.0 (down 95.41% YoY), while the FY2025 annual figure was $13000.0, down 95.41% from the prior year.
• Accumulated Expenses was $13000.0 for Q4 2025 at Cyclerion Therapeutics, down from $46000.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $4.3 million in Q3 2022 to a low of $13000.0 in Q4 2025.
• Historically, Accumulated Expenses has averaged $1.1 million across 5 years, with a median of $283000.0 in 2024.
• The sharpest annual moves came in 2023 and 2024: Accumulated Expenses tumbled 99.61% in 2023, then jumped 323.53% in 2024.
• A 5-year view of Accumulated Expenses shows it stood at $3.4 million in 2021, then slumped by 76.43% to $809000.0 in 2022, then retreated by 1.36% to $798000.0 in 2023, then tumbled by 64.54% to $283000.0 in 2024, then slumped by 95.41% to $13000.0 in 2025.
• The last three Accumulated Expenses figures came in at $13000.0 (Q4 2025), $46000.0 (Q3 2025), and $72000.0 (Q2 2025), per Business Quant data.